|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| C07K 16/10 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 16/32 | (2006.01) | ||
| C07K 16/46 | (2006.01) |
| (11) | Number of the document | 3016681 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14737200.7 |
| Date of filing the European patent application | 2014-07-04 | |
| (97) | Date of publication of the European application | 2016-05-11 |
| (45) | Date of publication and mention of the grant of the patent | 2019-12-18 |
| (46) | Date of publication of the claims translation | 2020-03-25 |
| (86) | Number | PCT/EP2014/064326 |
| Date | 2014-07-04 |
| (87) | Number | WO 2015/001085 |
| Date | 2015-01-08 |
| (30) | Number | Date | Country code |
| PCT/EP2013/0643 | 2013-07-05 | WO | |
| PCT/EP2014/0503 | 2014-01-09 | WO | |
| 201400009 | 2014-01-09 | DK |
| (72) |
VAN DEN BRINK, Edward, NL
NEIJSSEN, Joost J., NL
LABRIJN, Aran Frank, NL
MEESTERS, Joyce, NL
SCHUURMAN, Janine, NL
PARREN, Paul, NL
|
| (73) |
Genmab A/S,
Carl Jacobsens Vej 30, 2500 Valby,
DK
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Humanizuoti arba chimeriniai CD3 antikūnai |
| HUMANIZED OR CHIMERIC CD3 ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2025-06-04 | 12 | 289.00 EUR |
| 2026-07-04 |